Blog Injective November 24, 2020 News Related News March 09, 2025 · 5 min read ETH Denver 2025: Injective Recap “The Year of the Regenerates” was the motto of this year’s ETH Denver. The Injective Labs team attended in full force for a week-long conference including multiple stage talks, a multitude of business meetings, social events, and thousands of conversations with some of the 25,000+ total attendees at Community March 04, 2025 · 7 min read Libre, in Collaboration with Nomura’s Laser Digital, Expands Access to Blackrock Institutional Funds with Onchain Utility on Injective Today, Libre, a technology infrastructure platform allowing access to institutional and accredited investors, has unveiled a monumental integration that brings its platform for institutional fund issuance and distribution to Injective. This integration enables institutional and accredited investors to access a range of regulated, onchain investment funds, including the recently launched Tokenization February 27, 2025 · 3 min read Deutsche Telekom MMS, Joins Injective as a Validator Today, Deutsche Telekom MMS, a subsidiary of Deutsche Telekom, joins Injective’s validator set. This collaboration marks a pivotal step in bridging traditional enterprise infrastructure with cutting-edge blockchain technology, further solidifying Injective’s position as the most performant, institutional-friendly Layer 1 network. Expanding Web3 Infrastructure and Enterprise Adoption By operating Infrastructure News Related News March 09, 2025 · 5 min read ETH Denver 2025: Injective Recap “The Year of the Regenerates” was the motto of this year’s ETH Denver. The Injective Labs team attended in full force for a week-long conference including multiple stage talks, a multitude of business meetings, social events, and thousands of conversations with some of the 25,000+ total attendees at Community March 04, 2025 · 7 min read Libre, in Collaboration with Nomura’s Laser Digital, Expands Access to Blackrock Institutional Funds with Onchain Utility on Injective Today, Libre, a technology infrastructure platform allowing access to institutional and accredited investors, has unveiled a monumental integration that brings its platform for institutional fund issuance and distribution to Injective. This integration enables institutional and accredited investors to access a range of regulated, onchain investment funds, including the recently launched Tokenization February 27, 2025 · 3 min read Deutsche Telekom MMS, Joins Injective as a Validator Today, Deutsche Telekom MMS, a subsidiary of Deutsche Telekom, joins Injective’s validator set. This collaboration marks a pivotal step in bridging traditional enterprise infrastructure with cutting-edge blockchain technology, further solidifying Injective’s position as the most performant, institutional-friendly Layer 1 network. Expanding Web3 Infrastructure and Enterprise Adoption By operating Infrastructure Let's Go The future of finance starts here. The future of finance starts here. Join the journey in building true financial freedom for all. Join the journey in building true financial freedom for all. Discord Twitter Reddit GitHub YouTube Telegram